Abu Dhabi Stem Cells Center announced on April 5, 2026, a breakthrough technique that generates brain stem cells from a patient's own skin or blood cells, placing Abu Dhabi among a small group of global centers alongside institutions in the United States, Europe, and Asia conducting this research. The virus-free reprogramming process returns patient cells to an early developmental stage before guiding them to become neural stem cells under controlled conditions, reducing rejection risk while preserving genetic identity. The same platform can also produce heart and liver cells, demonstrating versatility in regenerative medicine applications. Led by research including Professor Angelo L. Vescovi from University of Milano-Bicocca, the center aims to develop future treatments for Parkinson's disease, Alzheimer's disease, ALS, and spinal cord injuries, with next phases focusing on scaling production and preparing for clinical applications.
Story comments
Loading comments…